Audit of treatment of Staphylococcus aureus bacteraemia

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Staphylococcus aureus bacteraemia remains a significant cause of morbidity and mortality. National guidelines recommend that a minimum of 14 days of antibiotics should be used to treat uncomplicated bacteraemia. Five hospitals in the East Midlands region conducted a retrospective audit to assess compliance to these guidelines before and after the introduction of extra text to laboratory reports of S. aureus bacteraemia advising clinicians on the minimum length of treatment. Introduction of this extra text resulted in an increase in compliance with the national recommendation from 44% to 60%. This increase in compliance was noted in both methicillin-sensitive S. aureus (45% versus 58%) and methicillin-resistant S. aureus (42% versus 62%) bacteraemia. This audit demonstrated a simple and effective intervention that has improved the treatment of this potentially life-threatening condition. © Royal College of Physicians, 2010. All rights reserved.

Cite

CITATION STYLE

APA

Wong, V., Wariyar, R., Weston, V., Olver, W. J., Youngs, E., Hussain, A., … Swann, A. (2010). Audit of treatment of Staphylococcus aureus bacteraemia. Clinical Medicine, Journal of the Royal College of Physicians of London, 10(3), 266–269. https://doi.org/10.7861/clinmedicine.10-3-266

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free